Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Cancer|March 13, 2010
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancerWilliam N William, Merrill S Kies, Frank V Fossella, et al.
Cancer|June 26, 2007
Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissectionRosa F Hwang, Ana M Gonzalez-Angulo, Min Yi, et al.
The Oncologist|December 15, 2015
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Diane D Liu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungsManisha Bhutani, Ashutosh Kumar Pathak, You-Hong Fan, et al.
The Oncologist|September 27, 2018
Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background PainAhsan Azhar, Yu Jung Kim, Ali Haider, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
Stem Cells (Dayton, Ohio)|September 17, 2013
A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cellsNorihiko Saito, Jun Fu, Siyuan Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosisXiming Tang, Humam Kadara, Carmen Behrens, et al.
Cancer|July 16, 2011
Early onset HER2-positive breast cancer is associated with germline TP53 mutationsAmal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, et al.
Palliative & Supportive Care|July 31, 2020
The development of a nomogram to determine the frequency of elevated risk for non-medical opioid use in cancer patientsSriram Yennurajalingam, Tonya Edwards, Joseph Arthur, et al.
Pageof 11